Table 3 Dose of PPIs and P-CAB for the initial treatment of EoE
From: Real world treatment patterns in patients with eosinophilic esophagitis in Japan
Main analysis (n = 615) | |
|---|---|
Medication | n (%) |
PPI (n=322) | |
Esomeprazole | |
20mg/day | 198 (32.2%) |
10mg/day | 24 (3.9%) |
Rabeprazole | |
20mg/day | 4 (0.7%) |
10mg/day | 58 (9.4%) |
Lansoprazole | |
30mg/day | 12 (2.0%) |
15mg/day | 22 (3.6%) |
Omeprazole | |
20mg/day | 2 (0.3%) |
10mg/day | 2 (0.3%) |
P-CAB (n=221) | |
Vonoprazan | |
20mg/day | 150 (24.4%) |
10mg/day | 71 (11.5%) |
